Figure 1 | Scientific Reports

Figure 1

From: Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study

Figure 1

Neutralizing antibodies (nAB) differed by vaccine type. A significant two-way interaction between time and vaccine type was identified. nAB increased over time for Janssen participants while decreasing over time for Moderna and Pfizer participants. At 6 months, Moderna was superior to Janssen, and both Moderna and Janssen were superior to Pfizer. Lines and shading represent model-derived estimated means +/− 95% CI for each combination of time and vaccine.

Back to article page